A stoichiometric C–H activation/decarbonylation of salicylaldehyde by [(η6‐p‐cymene)RuCl2]2 gave a carbonyl derivative [(η6‐p‐cymene)RuCl(CO)(Ph‐O)] (1) without the use of CO gas. A variety of polar phosphines were then incorporated into compound 1 to give new RuII cationic catalysts, [(η6‐p‐cymene)Ru(CO)(Ph‐O)L]BF4 (2–8). These were used to catalyse the hydrothiolation of alkynes with a range of thiols in aqueous THF to give anti‐Markovnikov E‐linear vinyl sulfides in high yields.
(where azi = 7-azaindolate, L = polar phosphine) were isolated from the reaction of [Rh(µ-Cl)(CO) 2 ] 2 with 7-azaindolate followed by some polar mono-and bis-phosphines (L 1 -L 8 ). A relationship between δ 31 P-NMR and ν(CO) values was considered to define the impact of polar-groups on σ -donor properties of the phosphines. These compounds were evaluated as catalyst precursors in the hydroformylation of 1-hexene and 1-dodecene both in mono-and biphasic aqueous organic systems. While the biphasic hydroformylations (water + toluene) gave exclusively the aldehydes, the monophasic one (aqueous ethanol) showed propensity to form both aldehydes and alcohols. The influence of bimetallic cooperative effects, and σ -donor and hydrophilic properties of the phosphines with pendant polar-groups in enhancing the yields and selectivity of hydroformylation products was emphasized. In addition, when strong σ -donor phosphine was used, the π -acceptor nature of pyridine ring of 7-azaindolate spacer was found to be a considerable factor in facilitating the facile cleavage of CO group during hydroformylation and in supplementing the cooperative effects. Copyright
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.